NACDS submitted comments to the Board of Pharmacy in support of proposed rule changes that would make permanent the temporary allowances for remote processing. These were granted by Gov. Kim Reynolds (R) and the Board of Pharmacy in response to the COVID-19 public health emergency. If adopted, the proposed rule would permit pharmacists to provide remote counseling services and allow certified pharmacy technicians to perform delegated functions at a location that is not a licensed pharmacy. 

Also in Iowa, the Board of The Board of Pharmacy has posted its meeting minutes from the March 1, 2022, meeting. 

Finally in Iowa, the Department of Human Services issued INFORMATIONAL LETTER NO. 2337-MC-FFS announcing the following June 2022 Iowa Medicaid Pharmacy Program Changes effective June 1, 2022. 

  1. Changes to the Preferred Drug List (PDL) Effective June 1, 2022 
  2. New Drug PA [Prior Authorization] Criteria – Triheptanoin (Dojolvi) 
  3. Changes to Existing PA [Prior Authorization] Criteria 
    1. Apremilast (Otezla) 
    2. Biologics for Arthritis 
    3. Janus Kinase Inhibitors 
    4. Selective Preventive Migraine Treatments (formerly CGRP Inhibitors) 
  1. Point of Sale Billing Updates – ProDUR Quantity Limits
  2. Drug Utilization Review (DUR) Update 
  3. Pharmacy Average Acquisition Cost (AAC) 
    1. AAC Rate Setting Process 
    2. Rate Review Requests  

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.